UI spin-off Viewpoint Molecular Targeting wins NIH awards
University of Iowa spin-off Viewpoint Molecular Targeting has recently been awarded a $2 million Phase II NIH SBIR to support development of a new treatment for metastatic melanoma.
Madeline A. Shea, PhD, professor of biochemistry and director of the FUTURE in Biomedicine Program , will receive the 2018 Emily M. Gray Award from the ...